Completed PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT00801307

Trial Comparing Effect of He/O2 to Medical Air on Pulmonary Function Disease

A Single Site,Exploratory,Phase I/II,Randomised Trial Comparing the Effect of He/O2 Mixtures(He/O2 78:22 and He/O2 65:35) to Medical Air on Pulmonary Function in Moderate/Severe Asthma and COPD Patients and Healthy Volunteers

Sponsor: Air Liquide SA

Conditions Asthma Chronic Obstructive Pulmonary Disease Healthy

Interventions spirometer

Updated 5 times since 2017 Last updated: Aug 8, 2014 Started: Jun 30, 2008 Primary completion: Mar 31, 2009 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Asthma and Chronic Obstructive Pulmonary Disease, this trial is completed. The trial is conducted by Air Liquide SA and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Air Liquide SA
Inamed

Data source: Air Liquide SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Robert-Koch-Allee 2, Germany